Recent Articles from GlobeNewswire
Wallbox and Famatel Announce Agreement for Famatel to Acquire ABL’s Connectivity Business
The transaction reinforces Wallbox’s specialization in EV charging solutions and opens a new stage for the Connectivity business under Famatel’s leadership and experience
By Wallbox Chargers S.A. · Via GlobeNewswire · November 19, 2026
Vivid Seats Enters Into Transaction Support Agreement for Comprehensive Recapitalization
Transaction Reduces Net Debt by $232 Million, Provides $66 Million of New First Lien, First Out Term Loans1, and Extends Term Loan Maturities to 2032
By Vivid Seats LLC · Via GlobeNewswire · November 19, 2026
Willis Lease Finance Corporation Expands Fleet with Acquisition of Two Airbus A320 Aircraft
COCONUT CREEK, Fla., Nov. 19, 2026 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) (the "Company"), the leading lessor of commercial aircraft engines and global provider of aviation services, today announces that it has completed the acquisition of two Airbus A320 aircraft.
By Willis Lease Finance Corp. · Via GlobeNewswire · November 19, 2026
Aetherion™ to Demonstrate CNG Heavy-Duty, HPDI Powered Trucks, Supported by C$2 Million Funding from Fuel Innovation Fund
Five-truck, 12-month demonstration will test the economic and scalable GHG reduction potential of natural gas and biogas technology in Canada
By Aetherion Technologies Canada Inc. · Via GlobeNewswire · November 19, 2026
LBank Exchange Listed VP (Voltapepe)
SINGAPORE, Nov. 19, 2026 (GLOBE NEWSWIRE) -- LBank Exchange, a leading global cryptocurrency trading platform, listed VP (Voltapepe) at 08:00am on Nov 18, 2026 (UTC).
By LBank · Via GlobeNewswire · November 19, 2026
EBI Reaches Key Milestone with First Patient Enrolled in Phase III EasyBoost Trial of EA-230, a Potential First-in-Class Medicine to Accelerate Recovery After Cardiac Surgery
The EasyBoost trial evaluates EA-230 as a potential new treatment option to improve recovery following major cardiac surgery, building on Phase II results in which patients treated with EA-230 had a two-day shorter median hospital stay (8 versus 10 days; p=0.001)
By Exponential Biotherapies, Inc. · Via GlobeNewswire · November 19, 2026
Newcore Gold Announces Submission of Mining Lease Application for the Enchi Gold Project, Ghana
VANCOUVER, British Columbia, Nov. 19, 2026 (GLOBE NEWSWIRE) -- Newcore Gold Ltd. ("Newcore" or the "Company") (TSX-V: NCAU, OTCQX: NCAUF) is pleased to announce the submission of a Mining Lease application for the Company's Enchi Gold Project ("Enchi" or the "Project") in Ghana. The Mining Lease application covers 53.37 km2 of the 248 km2 property.
By Newcore Gold Ltd. · Via GlobeNewswire · November 19, 2026
First Atlantic Nickel & Cobalt Attends Critical Minerals Briefing on Capitol Hill, Highlighting New Cerium Refining Technology That Extracted 98% of the Nickel and 82% of the Cobalt From Pipestone XL Awaruite (Ni-Fe-Co Alloy) in 20 Minutes Without
GRAND FALLS-WINDSOR, Newfoundland and Labrador, Nov. 19, 2026 (GLOBE NEWSWIRE) -- First Atlantic Nickel & Cobalt Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P210) ("First Atlantic" or the "Company") is pleased to announce its attendance at the Fastmarkets Critical Minerals and Materials Briefing, taking place today, November 19, 2026, on Capitol Hill in Washington, DC.1 The Company is attending to highlight the new cerium refining technology developed at Columbia University. As reported on November 18, 2026,2 the technology extracted 98% of the nickel and 82% of the cobalt in 20 minutes from awaruite (Ni-Fe-Co alloy) concentrate sourced from the Company's Pipestone XL Nickel-Cobalt Alloy Project, with approximately 90% of the nickel extracted within the first 5 minutes. The process operated at room temperature, with no smelting and no sulfuric acid pretreatment, as reported on November 18, 2026.3
By First Atlantic Nickel & Cobalt Corp. · Via GlobeNewswire · November 19, 2026
72% of holiday shoppers will use AI, but almost all still pair it with customer reviews before buying
Only 1% of holiday shoppers will buy an AI-recommended gift without checking reviews first, and just 15% of shoppers plan to let AI buy on their behalf
By Bazaarvoice, Inc. · Via GlobeNewswire · November 19, 2026
Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, Nov. 19, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced will participate in the following upcoming investor conferences:
By Zymeworks Inc. · Via GlobeNewswire · November 19, 2026
HUTCHMED Announces China NMPA Approval of SYVIK® (sovleplenib) for the Treatment of Primary Immune Thrombocytopenia and Warm Antibody Autoimmune Hemolytic Anemia
— SYVIK® becomes the first novel Syk inhibitor approved in China —
By HUTCHMED (China) Limited · Via GlobeNewswire · November 19, 2026
MoonFox Data Opens Continuous China LLM Usage Data to Global Investors and Research Firms
SHENZHEN, China, Nov. 19, 2026 (GLOBE NEWSWIRE) -- MoonFox Data, the full-scenario data insight and analytics specialist under Aurora Mobile (NASDAQ: JG), today set out how its China large language model (LLM) usage dataset gives global investors and research firms a continuous view of how much each leading Chinese model is actually being used — a measure that no provider publishes on a standardized, ongoing basis.
By MoonFox Data · Via GlobeNewswire · November 19, 2026
A Race Against Blindness Brings Back “Miles, Magic & Mochas” Fundraiser for the Holiday Season
Family-focused fundraiser returns with a 2026 Toyota Sienna Platinum, $20,000 Disney vacation award, Starbucks for a year, and $30,000 cash
By A Race Against Blindness · Via GlobeNewswire · November 19, 2026
GIA Explores the Changing World of Pearls This Holiday Season
From red carpets and runways to everyday jewelry, GIA highlights the diversity of pearls and their growing role in personal style
By Gemological Institute of America, Inc. · Via GlobeNewswire · November 19, 2026
MEXC's Hacken-Audited November 2026 Proof of Reserves Shows Reserve Ratios Above 100% Across Major Assets
By MEXC · Via GlobeNewswire · November 19, 2026
Arcera Life Sciences and Innogen Pharmaceuticals Sign Exclusive Licensing Agreement to Expand Access to Cardiometabolic Care Across International Markets
Agreement marks a significant step in Arcera’s strategy to strengthen its cardiometabolic franchise and broaden its portfolio of innovative medicines across international markets.
By Arcera Life Sciences · Via GlobeNewswire · November 19, 2026
Transaction in Own Shares
Transaction in Own Shares
By Shell plc · Via GlobeNewswire · November 19, 2026
Economic resilience masks tougher conditions for businesses in 2027
AMSTERDAM, Nov. 19, 2026 (GLOBE NEWSWIRE) -- The world economy is proving more resilient than expected, but businesses face a more challenging environment in 2027 as high energy prices, renewed inflationary pressure, and higher-for-longer interest rates weigh on the outlook, according to Atradius’s latest Economic Research Department forecasts.
By Atradius N.V. · Via GlobeNewswire · November 19, 2026
Exolum enters U.S. pipeline operations with the acquisition of a pipeline system in Houston
HOUSTON, Nov. 19, 2026 (GLOBE NEWSWIRE) -- Exolum has completed the acquisition of a pipeline system from Boardwalk serving industrial customers in the Houston Ship Channel area.
By Exolum · Via GlobeNewswire · November 19, 2026
Robinson Helicopter Company Extends R66 12-Year Inspection Interval to 15 Years
Proven R66 Reliability Delivers Even Greater Value and Lower Long-Term Ownership Costs
By Robinson Helicopter Company · Via GlobeNewswire · November 19, 2026
Futu Announces Third Quarter 2026 Unaudited Financial Results
HONG KONG, Nov. 19, 2026 (GLOBE NEWSWIRE) -- Futu Holdings Limited (“Futu” or the “Company”) (Nasdaq: FUTU), a leading tech-driven online brokerage and wealth management platform, today announced its unaudited financial results for the third quarter ended September 30, 2026.
By Futu Holdings Limited · Via GlobeNewswire · November 19, 2026
Sunlands Technology Group Announces Unaudited Third Quarter 2026 Financial Results
BEIJING, Nov. 19, 2026 (GLOBE NEWSWIRE) -- Sunlands Technology Group (NYSE: STG) (“Sunlands” or the “Company”), a leader in China’s adult online education market and China’s adult personal interest learning market, today announced its unaudited financial results for the third quarter ended September 30, 2026.
By Sunlands Technology Group · Via GlobeNewswire · November 19, 2026
Recover™ and SUPIMA® Partner to Advance Circularity in Premium Cotton
The global partnership brings together SUPIMA’s American Pima cotton heritage with Recover’s recycling expertise, creating new recycled fiber and yarn solutions from SUPIMA® cotton waste
By Recover™ · Via GlobeNewswire · November 19, 2026
AVA6207 Overcomes Topoisomerase I Inhibitor Resistance In Vitro and In Vivo with Robust and Tumor-Selective Release of Dual Exatecan and ATR Inhibitor Payloads
The two clinical scenarios of ATM loss and SLFN11 loss are found across multiple indications and identify key patient populations for clinical development
By Avacta Group PLC · Via GlobeNewswire · November 19, 2026
Press Release: Sanofi’s next-generation rabies vaccine, VaxRabeo, approved in the EU for all ages
Sanofi’s next-generation rabies vaccine, VaxRabeo, approved in the EU for all ages
By Sanofi Winthrop Industrie · Via GlobeNewswire · November 19, 2026
OSL Group Advancing Strategic Middle East Expansion with VARA In-Principle Approval for Broker-Dealer Services
DUBAI, United Arab Emirates, Nov. 19, 2026 (GLOBE NEWSWIRE) -- OSL Group (HKEX: 863) (“OSL”), a global stablecoin payment and trading infrastructure company, today announced that its Dubai-based entity, OSL MENA FZE, has been awarded an In-Principle Approval (IPA) for Broker-Dealer Services by Dubai’s Virtual Assets Regulatory Authority (VARA).
By OSL Group · Via GlobeNewswire · November 19, 2026
Global Electronics Association: Growing Shortages Across the PCB Supply Chain Threaten the Next Wave of AI and Electronics
Bannockburn, Illinois, USA, Nov. 19, 2026 (GLOBE NEWSWIRE) -- The Global Electronics Association, the voice of the electronics industry, is issuing this Industry Alert on escalating shortages across the printed circuit board (PCB) supply chain. Companies in automotive, industrial, medical, defense, and telecommunications report longer lead times and difficulty securing supply as AI absorbs scarce capacity, effectively putting production at risk. Availability, not price, is the real risk facing the industry and outlined in the Explanatory Report, “PCB Squeeze: A Wake-Up Call for Global Electronics.”
By Global Electronics Association · Via GlobeNewswire · November 19, 2026
Noitom Robotics Ranked No. 1 in Asia on The Information's 50 Most Promising Startups of 2026
The Information lists the Physical AI data company at a valuation above $500 million, with revenue above $10 million
By Noitom Robotics · Via GlobeNewswire · November 18, 2026
UNFPA warns: the world risks letting the next generation down
A mix of economic instability, inequality, exclusion and other destabilizing factors are holding young people back from fulfilling their ambitions
By UNFPA · Via GlobeNewswire · November 18, 2026
PawSwing Closes Pre-Series A Funding Round
PawSwing introduced what it describes as the world’s first automatic cat grooming device in 2024.
By Pawswing.INC · Via GlobeNewswire · November 18, 2026
Honeywell Aerospace Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Honeywell Aerospace, Inc. - HONA
NEW ORLEANS, Nov. 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 23, 2026 to file lead plaintiff applications in a securities class action lawsuit against Honeywell Aerospace, Inc. (“Honeywell Aerospace” or the “Company”) (NasdaqGS: HONA), if they purchased Honeywell Aerospace, Inc. shares on the open market between June 29, 2026 and September 1, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Arizona.
By SkyMedia, LLC · Via GlobeNewswire · November 18, 2026
Fangzhou and Baiyunshan Pharmaceutical Launch AI-Powered Chronic Disease Management Initiative
GUANGZHOU, China, Nov. 19, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, announced a strategic partnership with Baiyunshan Pharmaceutical General Factory (“Baiyunshan Pharmaceutical”) at its 2026 Double 12 Partner Conference in Guangzhou, as the companies seek to expand AI-powered healthcare services and develop new digital marketing solutions.
By Fangzhou Inc. · Via GlobeNewswire · November 18, 2026
LevelTen Energy Expands into Asia-Pacific To Scale Global Clean Power Markets
Expansion will begin in India with a 500 MW RFP on behalf of a global hyperscaler
By LevelTen Energy · Via GlobeNewswire · November 18, 2026
Agencia Comercial Spirits Ltd Announces Execution of MEP Equipment Supply and Installation Contracts for Phase 1B of Indonesia Data Center
TAICHUNG, Taiwan, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Agencia Comercial Spirits Ltd (the “Company”) today announced that on November 13, 2026, its Indonesian operating subsidiary, PT AGCC AITECH INDONESIA (the “Indonesian Subsidiary”), entered into two definitive contracts with separate contractors for the mechanical, electrical and plumbing (“MEP”) works for Phase 1B of the Company’s planned AGCC-JKT01 data center in West Java, Indonesia (the “Data Center”): an equipment supply agreement for the procurement and supply of MEP equipment (the “Supply Contract”) and an installation works contract for the installation of the MEP equipment and systems (the “Installation Contract” and, together with the Supply Contract, the “Contracts”). The Contracts are in addition to the letters of award for the MEP equipment and installation works for Phase 1A of the Data Center previously announced by the Company on September 1, 2026.
By Agencia Comercial Spirits Ltd · Via GlobeNewswire · November 18, 2026
Gildan Activewear Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Gildan Activewear Inc. - GIL
NEW ORLEANS, Nov. 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 14, 2026 to file lead plaintiff applications in a securities class action lawsuit against Gildan Activewear Inc. (“Gildan” or the “Company”) (NYSE: GIL), if they purchased or otherwise acquired the Company’s publicly traded securities between February 19, 2025 and June 15, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of New York.
By SkyMedia, LLC · Via GlobeNewswire · November 18, 2026
Duolingo Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Duolingo, Inc. - DUOL
NEW ORLEANS, Nov. 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against Duolingo, Inc. (“Duolingo” or the “Company”) (NasdaqGS: DUOL), if they purchased Duolingo, Inc. Class A common stock between May 2, 2025 and February 26, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Western District of Pennsylvania.
By SkyMedia, LLC · Via GlobeNewswire · November 18, 2026
Everest Group Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Everest Group, Ltd. - EG
NEW ORLEANS, Nov. 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 28, 2026 to file lead plaintiff applications in a securities class action lawsuit against Everest Group, Ltd. (“Everest” or the “Company”) (NYSE: EG), if they purchased or otherwise acquired Everest common stock between February 8, 2024 and October 27, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
By SkyMedia, LLC · Via GlobeNewswire · November 18, 2026
Millrose Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Millrose Properties, Inc. - MRP
NEW ORLEANS, Nov. 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 8, 2026 to file lead plaintiff applications in a securities class action lawsuit against Millrose Properties, Inc. (“Millrose” or the “Company”) (NYSE: MRP), if they purchased or otherwise acquired Millrose Properties, Inc. securities between February 7, 2025 and October 2, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of Florida.
By SkyMedia, LLC · Via GlobeNewswire · November 18, 2026
Ensign Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against The Ensign Group, Inc. - ENSG
NEW ORLEANS, Nov. 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Ensign Group, Inc. (“Ensign” or the “Company”) (NasdaqGS: ENSG), if they purchased or otherwise acquired The Ensign Group, Inc. securities between February 10, 2022 and June 18, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.
By SkyMedia, LLC · Via GlobeNewswire · November 18, 2026
Chemours Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against The Chemours Company - CC
NEW ORLEANS, Nov. 18, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company (“Chemours” or the “Company”) (NYSE: CC), if they purchased or otherwise acquired The Chemours Company securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Delaware.
By SkyMedia, LLC · Via GlobeNewswire · November 18, 2026
RecycLiCo Announces Results of 2026 Annual General Meeting of Shareholders
DELTA, British Columbia, Nov. 18, 2026 (GLOBE NEWSWIRE) -- RecycLiCo Battery Materials Inc. (“RecycLiCo” or the “Company”) (TSX.V: AMY | OTCQB: AMYZF | FSE: ID4), a critical minerals refining and lithium-ion battery upcycling company, is pleased to announce the results of its 2026 Annual General Meeting of Shareholders, held November 17, 2026.
By RecycLiCo Battery Materials · Via GlobeNewswire · November 18, 2026
FDA Approves Livsayis™ (cemdisiran) for Adults Living with Generalized Myasthenia Gravis
This new treatment is the first and only FDA approved siRNA therapy for gMG, expanding the therapeutic landscape for people living with myasthenia gravis.
By Muscular Dystrophy Association · Via GlobeNewswire · November 18, 2026
Enerflex Ltd. Announces CFO Transition
CALGARY, Alberta, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) today announced the appointment of Christine Morris as Senior Vice President and Chief Financial Officer, effective January 1, 2027. Ms. Morris will succeed Preet S. Dhindsa, who will step down from his role effective December 31, 2026.
By Enerflex Ltd. · Via GlobeNewswire · November 18, 2026
HUTCHMED Highlights HMPL-A830 Pre-Clinical Data Presented at the 38th EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
— A novel EGFR-directed ATTC with a potent pan-KRAS payload designed to overcome resistance and systemic toxicity associated with EGFR/KRAS inhibition —
By HUTCHMED (China) Limited · Via GlobeNewswire · November 18, 2026
Brookie Beauty LLC Announces TreStyler Launch and International Media Expansion
ENGLEWOOD CLIFFS, NJ, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Brookie Beauty LLC, the company behind the TreStyler 3-in-1 hair styling iron, has announced the upcoming November 15 launch of its product through its official website and Amazon, alongside plans for international media testing and a distribution partnership in Japan.
By Brookie Beauty LLC · Via GlobeNewswire · November 18, 2026
QFIN STOCKHOLDER REMINDER: Qfin Holdings, Inc. Investors Have Until November 30th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
If you purchased or acquired Qfin securities between March 18, 2026 and August 25, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.
By Bragar Eagel & Squire · Via GlobeNewswire · November 18, 2026
Endava plc Investors Have Until November 30th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Endava (DAVA) To Contact Them Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 18, 2026
Bragar Eagel & Squire, P.C. Reminds Fluence Energy, Inc. Investors to Contact the Firm Regarding Their Rights Before November 30th
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fluence (FLNC) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 18, 2026
AVXL INVESTOR DEADLINE ALERT: Anavex Life Sciences Corp. Investors Seeking Lead Plaintiff Role Have Until November 30th to Contact Bragar Eagel & Squire, P.C.
If you purchased or acquired Anavex securities between November 26, 2025 and August 28, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.
By Bragar Eagel & Squire · Via GlobeNewswire · November 18, 2026
Bragar Eagel & Squire, P.C. is Investigating NVIDIA Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nvidia (NVDA) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 18, 2026
ISSA Show North America Redefines Innovation with 2026 Award Winners Shaping the Future of Clean
Spotlighting game-changing technologies and solutions, this year's Innovation Program was reimagined to recognize evolving industry demands
By Informa Markets Infrastructure & Construction · Via GlobeNewswire · November 18, 2026
Livsayis™ (cemdisiran) Approved by the FDA as First and Only siRNA Therapy in Generalized Myasthenia Gravis and Only Treatment with Four-Times-a-Year Subcutaneous Dosing
Approval based on Phase 3 NIMBLE results demonstrating rapid, deep and sustained disease control that is maintained throughout three-month dosing intervals
By Regeneron Pharmaceuticals, Inc. · Via GlobeNewswire · November 18, 2026
Pyxis Oncology to Host Live Webcast on Updated MICVO Phase 1 Monotherapy Data Demonstrating Durable Response in 2L+ R/M HNSCC Following Late-Breaking Oral Presentation at EORTC-NCI-AACR Symposium
Updated data from a more mature October 2026 data cutoff show rapid and deep responses, with a 39% confirmed ORR, median duration of response of 9.2 months and median PFS of 6.7 months
By Pyxis Oncology · Via GlobeNewswire · November 18, 2026
Northrop Grumman Board Declares Quarterly Dividend
FALLS CHURCH, Va., Nov. 18, 2026 (GLOBE NEWSWIRE) -- The board of directors of Northrop Grumman Corporation (NYSE: NOC) declared a quarterly dividend of $2.47 per share on Northrop Grumman common stock, payable December 16, 2026, to shareholders of record as of the close of business November 30, 2026. Northrop Grumman continues to execute a disciplined capital allocation strategy that prioritizes investments in the manufacturing capabilities and capacity needed to deliver differentiating technologies quickly for our customers.
By Northrop Grumman Corporation · Via GlobeNewswire · November 18, 2026
A Medicare Open Enrollment Checklist: Planning for 2027 Coverage
NEW YORK, Nov. 18, 2026 (GLOBE NEWSWIRE) -- (Feature Impact) Whether you’re new to Medicare or considering a change to your current coverage, Medicare Open Enrollment is an opportunity to ensure health coverage meets your needs.
By Feature Impact · Via GlobeNewswire · November 18, 2026
YIREN CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Yiren Digital Ltd. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Yiren (YRD) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 18, 2026
Press Release: Sanofi’s Infilbray approved in the US as the first medicine to treat neurological manifestations of Type 3 Gaucher disease
Sanofi’s Infilbray approved in the US as the first medicine to treat neurological manifestations of Type 3 Gaucher disease
By Sanofi Winthrop Industrie · Via GlobeNewswire · November 18, 2026
O-I GLASS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against O-I Glass, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In O-I Glass (OI) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · November 18, 2026
Enovix Distributes Dividend of Warrants to Stockholders
FREMONT, Calif., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix” or the “Company,” Nasdaq: ENVX), a developer and manufacturer of advanced lithium-ion batteries, today announced that it will distribute warrants to purchase Enovix common stock (“Warrants”) to its stockholders and certain convertible noteholders on November 18, 2026 (the “Distribution Date”), in accordance with the previously declared stockholder warrant dividend. As previously announced, each stockholder of record as of the close of business on November 13, 2026 (the “Record Date”) will receive one (1) Warrant for every four (4) shares of Enovix common stock held, rounded down to the nearest whole Warrant.
By Enovix Corporation · Via GlobeNewswire · November 18, 2026
Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company
Teva's Pivot to Growth Strategy, R&D priorities, and expectations remain unchanged; Company initiates search for successor
By Teva Pharmaceutical Industries Ltd · Via GlobeNewswire · November 18, 2026
Alamos Gold Cautions Shareholders Regarding Newcastle Capital Partners’ Mini-Tender Offer For Shares
By Alamos Gold Inc. · Via GlobeNewswire · November 18, 2026
Palvella Therapeutics to Host Webcast to Introduce New QTORIN™ Program
Third product candidate from Palvella’s QTORIN™ platform to be announced
By Palvella Therapeutics Inc. · Via GlobeNewswire · November 18, 2026
OTTAWA BANCORP, INC. ANNOUNCES CASH DIVIDEND
Contact: Craig Hepner President and Chief Executive Officer (815) 366-5437
By Ottawa Bancorp, Inc. · Via GlobeNewswire · November 18, 2026
Beyond The Ballroom: The Atlas Hotel Expands Meetings & Events Capabilities for a New Way to Gather in Boston for 2027
BOSTON, Nov. 18, 2026 (GLOBE NEWSWIRE) -- The Atlas Hotel is expanding what a Boston meeting can be. The 246-room boutique hotel opened in early 2026 at the gateway of the Enterprise Research Campus on 40 Western Avenue, bringing a new gathering place to Allston and Cambridge. For 2027, The Atlas is introducing a suite of meetings and events capabilities that further connect the hotel spaces with the dynamic surrounding campus. Planners coming to Boston now have something never before offered in the city: a full campus for gathering, perfect proximity to city centers, exceptional value, and immersive experiences built inside the city’s most forward-looking district.
By The Atlas Hotel · Via GlobeNewswire · November 18, 2026
MEDIROM Announces Receipt of Nasdaq Delisting Notice, Filing of Annual Report and Submission of Hearing Request
TOKYO, Nov. 18, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq: MRM) (the “Company”) today announced that on November 13, 2026, it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) because the Company had not filed its Annual Report on Form 20-F for the year ended December 31, 2025 (the “Annual Report”) within the extension period previously granted by Nasdaq and therefore had not regained compliance with Nasdaq Listing Rule 5250(c)(1).
By MEDIROM Healthcare Technologies Inc. · Via GlobeNewswire · November 18, 2026
Xos Enters Energy Generation with the Xos Solar System, Bringing Grid-Independent Power to Any Site in Days
For operations that cannot depend on the grid, the Xos Solar System delivers energy independence from a single deployable system.
By Xos, Inc. · Via GlobeNewswire · November 18, 2026
Onco360® Has Been Selected as a National Pharmacy Partner for PIMJETMI® (pimicotinib)
LOUISVILLE, K.Y., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected by EMD Serono for PIMJETMI® (pimicotinib), indicated for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection may cause worsening functional limitations or severe morbidity.1
By Onco360 Oncology Pharmacy · Via GlobeNewswire · November 18, 2026
Cyabra Announces 30-to-1 Reverse Stock Split
New York, NY, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Cyabra, Inc. (Nasdaq: CYAB) (“Cyabra” or the “Company”), an artificial intelligence (“AI”)-powered narrative intelligence company that helps governments and enterprises detect coordinated manipulation and protect digital trust, today announced that a reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”) at a ratio of 30-for-1 is expected to be implemented at the market open on November 23, 2026. The Company’s Common Stock will begin trading on the Nasdaq Global Market on a post-split basis at the market open on November 23, 2026, under the Company’s existing trading symbol “CYAB”, but will trade under a new CUSIP Number, 23249H204.
By Cyabra · Via GlobeNewswire · November 18, 2026
Universal Health Services, Inc. Announces Dividend
KING OF PRUSSIA, Pa., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Universal Health Services, Inc. (NYSE: UHS) announced today that its Board of Directors voted to pay a cash dividend of $0.20 per share on December 15, 2026 to shareholders of record as of December 1, 2026.
By Universal Health Services, Inc. · Via GlobeNewswire · November 18, 2026
KBR Appoints Claudia Jaramillo to Board of Directors
HOUSTON, Nov. 18, 2026 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR) announced today the appointment of Claudia Jaramillo to its board of directors effective November 18, 2026.
By Kellogg Brown & Root LLC. · Via GlobeNewswire · November 18, 2026
ProKidney Names Farah Ali, M.D., M.S., Chief Medical Officer
Dr. Ali expands her role at ProKidney, bringing experience as a board-certified pediatric nephrologist and clinical development leader as the Company prepares for anticipated clinical milestones and regulatory filings
By ProKidney · Via GlobeNewswire · November 18, 2026
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune and inflammatory diseases, today announced that on November 16, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase an aggregate of 225,000 shares of the Company’s common stock (“Stock Options”) and an aggregate of 9,000 restricted stock units of the Company’s common stock (“RSUs”) to newly hired employees of the Company as an inducement material to such employees’ entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).
By Zenas BioPharma · Via GlobeNewswire · November 18, 2026
FARMERS AND MERCHANTS BANCSHARES, INC. DECLARES A CASH DIVIDEND OF $0.37 PER SHARE, INCREASING ANNUAL DIVIDENDS BY 7.4%
HAMPSTEAD, Md., Nov. 18, 2026 (GLOBE NEWSWIRE) -- On November 16, 2026, the Board of Directors of Farmers and Merchants Bancshares, Inc. (the “Company”), the parent of Farmers and Merchants Bank (the “Bank”), declared a cash dividend on the common stock of $0.37 per share, which will be paid on December 16, 2026, to stockholders of record on December 4, 2026. The $0.37 dividend represents a 3% increase over the dividend paid in June 2026 and an annualized dividend payout ratio of 34%. With this dividend, total dividends paid in 2026 will amount to $0.73 per share, representing a 7.4% increase over the $0.68 per share in total dividends paid in 2025.
By Farmers and Merchants Bancshares, Inc. · Via GlobeNewswire · November 18, 2026
Reservations Group Hosted World Hospitality Awards & Symposium 2026 at the Iconic Boca Raton Resort, Celebrating Global Hospitality and 50 Years of Disco
Legendary recording artists Anita Ward, Thelma Houston, and Rozalla were honored as the evening celebrated the hospitality industry, global partnerships, and the future of travel
By Reservations Group · Via GlobeNewswire · November 18, 2026
BillionToOne Responds to Inaccurate and Misleading Short Seller Report
MENLO PARK, Calif., Nov. 18, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a molecular diagnostics company today responded to a report published on November 18, 2026 by Fuzzy Panda Research, a short seller that, by its own disclosure, holds a short position in BillionToOne securities and stands to profit from driving down the company’s stock price.
By BillionToOne, Inc. · Via GlobeNewswire · November 18, 2026
